D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$986M |
| 2 |
Sea Limited
SE
|
+$480M |
| 3 |
Snowflake
SNOW
|
+$441M |
| 4 |
Citigroup
C
|
+$422M |
| 5 |
Oracle
ORCL
|
+$393M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$575M |
| 2 |
Apple
AAPL
|
+$515M |
| 3 |
Mastercard
MA
|
+$506M |
| 4 |
Walt Disney
DIS
|
+$447M |
| 5 |
Alibaba
BABA
|
+$434M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.34% |
| 2 | Consumer Discretionary | 9.18% |
| 3 | Financials | 7.38% |
| 4 | Healthcare | 6.92% |
| 5 | Communication Services | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
PUT
Zoetis
ZTS
$32.7B
| $2.44M | ﹤0.01% |
10,000
| – | – |
|
|
HUGS
3027
DELISTED
USHG Acquisition Corp.
HUGS
| $2.44M | ﹤0.01% |
235,149
+63,771
| +37% | +$645K |
|
3028
Ovid Therapeutics
OVID
$427M
| $2.44M | ﹤0.01% |
759,096
+30,166
| +4% | +$103K |
|
3029
PUT
Protolabs
PRLB
$1.7B
| $2.43M | ﹤0.01% |
47,300
-3,500
| -7% | -$207K |
|
3030
PUT
Coursera
COUR
$1.77B
| $2.42M | ﹤0.01% |
+99,200
| New | +$3.02M |
|
3031
PUT
DuPont de Nemours
DD
$18.6B
| $2.42M | ﹤0.01% |
23,900
| – | – |
|
|
ACB
3032
PUT
Aurora Cannabis
ACB
$169M
| $2.42M | ﹤0.01% |
44,730
| – | – |
|
|
DOC
3033
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $2.42M | ﹤0.01% |
128,540
+77,042
| +150% | +$1.42M |
|
3034
ESCO Technologies
ESE
$7.77B
| $2.42M | ﹤0.01% |
26,849
-20,493
| -43% | -$1.77M |
|
3035
CALL
KE Holdings
BEKE
$17.7B
| $2.41M | ﹤0.01% |
120,000
| – | – |
|
|
VTLE
3036
PUT
DELISTED
Vital Energy
VTLE
| $2.4M | ﹤0.01% |
40,000
+10,000
| +33% | +$706K |
|
|
IACC
3037
DELISTED
ION Acquisition Corp 3 Ltd.
IACC
| $2.4M | ﹤0.01% |
245,868
-397
| -0.2% | -$3.88K |
|
3038
Medifast
MED
$107M
| $2.4M | ﹤0.01% |
+11,474
| New | +$2.37M |
|
3039
CALL
Biogen
BIIB
$30.9B
| $2.4M | ﹤0.01% |
+10,000
| New | +$2.57M |
|
3040
Fresenius Medical Care
FMS
$13.4B
| $2.4M | ﹤0.01% |
+73,880
| New | +$2.43M |
|
|
WINV
3041
DELISTED
WinVest Acquisition Corp. Common Stock
WINV
| $2.39M | ﹤0.01% |
+243,000
| New | +$2.39M |
|
|
GIAC
3042
DELISTED
Gesher I Acquisition Corp. Class A Ordinary Shares
GIAC
| $2.39M | ﹤0.01% |
+243,793
| New | +$2.39M |
|
3043
PUT
Ciena
CIEN
$46.8B
| $2.39M | ﹤0.01% |
31,000
+1,000
| +3% | +$61.7K |
|
3044
SunCar Technology Group
SDA
$78.9M
| $2.38M | ﹤0.01% |
239,460
+59,609
| +33% | +$591K |
|
3045
ScottsMiracle-Gro
SMG
$4.09B
| $2.38M | ﹤0.01% |
14,784
-119,677
| -89% | -$18.5M |
|
3046
Ginkgo Bioworks
DNA
$498M
| $2.38M | ﹤0.01% |
7,157
-15,198
| -68% | -$7.22M |
|
|
RWT
3047
Redwood Trust
RWT
$588M
| $2.38M | ﹤0.01% |
180,158
+103,618
| +135% | +$1.4M |
|
3048
PUT
ICICI Bank
IBN
$107B
| $2.38M | ﹤0.01% |
120,000
| – | – |
|
|
EVBG
3049
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $2.38M | ﹤0.01% |
35,282
+32,237
| +1,059% | +$3.9M |
|
3050
CALL
Otis Worldwide
OTIS
$27.9B
| $2.37M | ﹤0.01% |
27,200
| – | – |
|
Similar funds
D.E. Shaw & Co's Q4 2021 Portfolio in Review
As of Q4 2021, D.E. Shaw & Co held 5,958 positions worth $121B, up 8.8% from $111B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co's Q4 2021 filing shows 1,033 new, 1,969 increased, 1,595 reduced and 616 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 2,140,000 shares worth $1.02B. The largest sale was Microsoft, an estimated $575M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
- D.E. Shaw & Co's largest Q4 2021 buy was iShares Core S&P 500 ETF: 2,140,000 shares worth $1.02B.
- D.E. Shaw & Co added most to Sea Limited in Q4 2021, an estimated $480M increase.
- D.E. Shaw & Co's biggest Q4 2021 reduction was Microsoft, cutting an estimated $575M.
- D.E. Shaw & Co fully exited Aon in Q4 2021, selling an estimated $179M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $121B portfolio in Q4 2021.
- D.E. Shaw & Co opened 1,033 new positions and closed 616 in Q4 2021.
- D.E. Shaw & Co's portfolio value rose 8.8% quarter-over-quarter to $121B.
Based on D.E. Shaw & Co's 13F filing for Q4 2021, filed 14 Feb 2022.